Angelia Felton-Wilks
Psychiatric/Mental Health · Milwaukee, WINPI 1669720041
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$821
- Otsuka America Pharmaceutical, Inc.$654
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$586
- Axsome Therapeutics, Inc.$376
- Johnson & Johnson$339
- AstraZeneca$204
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,35098%
- Education$752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $821 |
| Otsuka America Pharmaceutical, Inc. | 36 | $654 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $586 |
| Axsome Therapeutics, Inc. | 12 | $376 |
| Johnson & Johnson | 14 | $339 |
| AstraZeneca | 11 | $204 |
| Lilly USA, LLC | 11 | $189 |
| Bayer | 7 | $125 |
| Alkermes, Inc. | 2 | $122 |
| Novo Nordisk | 4 | $120 |
| Boehringer Ingelheim | 4 | $90 |
| Viatris Specialty LLC | 3 | $84 |
| Amgen | 4 | $76 |
| Lundbeck LLC | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $65 |
| Pfizer | 3 | $61 |
| Neurocrine Biosciences, Inc. | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Paratek Pharmaceuticals, Inc. | 3 | $53 |
| Indivior Inc. | 3 | $43 |
| Nestle Healthcare Nutrition Inc. | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Mylan Specialty L.p. | 1 | $24 |
| Abbott | 1 | $23 |
| Inogen, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Viiv Healthcare Company | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Aucta Pharmaceuticals, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,425 in reported general payments places this provider in the 90th percentile of 384 psychiatric/mental health providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 16 | $115,404 |
| VraylarCariprazine Hcl | 43 | $61,782 |
| Invega SustennaPaliperidone Palmitate | 12 | $21,453 |
| RexultiBrexpiprazole | 13 | $19,183 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,135 |
| Ramelteon | 15 | $1,798 |
| Aripiprazole | 33 | $648 |
| Hydroxyzine Hcl | 35 | $569 |
| Mirtazapine | 25 | $529 |
| Duloxetine Hcl | 22 | $521 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $350 |
| Guanfacine Hcl ErGuanfacine Hcl | 15 | $312 |
| Escitalopram Oxalate | 51 | $308 |
| Buspirone Hcl | 24 | $279 |
| Trazodone Hcl | 44 | $256 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $56 | $115,40416 claims |
| AbbVieVraylar | $821 | $61,78243 claims |
| Johnson & JohnsonInvega Sustenna | $339 | $21,45312 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $654 | $19,18313 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $16 | $6,13512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 384 psychiatric/mental health providers in Wisconsin.
Other psychiatric/mental health in Milwaukee
- Carolyn DavidsonMilwaukee$46K
- Sherry AleksichMilwaukee$33K
- Ngozi ObioraMilwaukee$19K
- Victoria McGinleyMilwaukee$9K
- Andrea MitchellMilwaukee$6K
- Angeline VercauterenMilwaukee$6K
- Lisa CwiklaMilwaukee$5K
- Julia JasterMilwaukee$5K
- Kristen AndersonMilwaukee$4K
- Julianne JohnMilwaukee$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.